J&J to exit spinoff Kenvue with latest stake sale valued at $3.75B

Business handshake on finance prosperity and money technology asset background . Economy and financial growth by investment in valuable stock market to gain wealth profit form currency trading

Kenvue Inc., the consumer health business that Johnson & Johnson spun out last year, on Monday said it will exchange 182.3 million shares of its common stock.

The “debt-for-equity” exchange looks to be worth about $3.75 billion, based on Kenvue’s Friday closing share price of $20.54.

New Brunswick-based J&J will then have no stake left in Kenvue.

In a Monday filing with the U.S. Securities and Exchange Commission, J&J said it would exchange its holding to Goldman Sachs and J.P. Morgan Securities for its debt.

“Following the debt-for-equity exchange, if consummated, the selling shareholders intend to sell the shares to the underwriters in the offering,” Kenvue said in a statement.